This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2002 Nov;8(6):817-21.

doi: 10.1046/j.1365-2516.2002.00685.x.

Unresolved issues in prophylaxis

S A Brown¹, L M Aledort, J Astermark, E Berntorp, M van den Berg, V Blanchette, S Donfield, A Gringeri, M Hilgartner, R Kulkarni, C Leissinger, C Negrier, R Nuss, H Petterson, P Petrini, N Poulios, W Schramm; Round Table Group

Affiliations

PMID: 12410654
DOI: 10.1046/j.1365-2516.2002.00685.x

Unresolved issues in prophylaxis

S A Brown et al. Haemophilia. 2002 Nov.

. 2002 Nov;8(6):817-21.

doi: 10.1046/j.1365-2516.2002.00685.x.

Authors

S A Brown¹, L M Aledort, J Astermark, E Berntorp, M van den Berg, V Blanchette, S Donfield, A Gringeri, M Hilgartner, R Kulkarni, C Leissinger, C Negrier, R Nuss, H Petterson, P Petrini, N Poulios, W Schramm; Round Table Group

Affiliation

¹ Katharine Dormandy Haemophilia Centre & Haemostasis Unit, Royal Free Hospital, London, UK. simon.brown@rfh.nthames.nhs.uk

PMID: 12410654
DOI: 10.1046/j.1365-2516.2002.00685.x

No abstract available

PubMed Disclaimer

Similar articles

Prophylactic factor replacement in hemophilia.
Carcao MD, Aledort L. Carcao MD, et al. Blood Rev. 2004 Jun;18(2):101-13. doi: 10.1016/S0268-960X(03)00038-9. Blood Rev. 2004. PMID: 15010149 Review.
Orthopaedic evaluation in children with severe haemophilia A or B submitted to primary prophylaxis therapy in a coagulopathy treatment centre.
De Podestá Haje D, Ono F, De Oliveira GB, Almeida J, De Paula JC, Batista Neto LV, Silva Barros SB. De Podestá Haje D, et al. Haemophilia. 2011 Mar;17(2):228-32. doi: 10.1111/j.1365-2516.2010.02421.x. Epub 2010 Nov 11. Haemophilia. 2011. PMID: 21070500
Experience with prophylaxis in Sweden.
Nilsson IM. Nilsson IM. Semin Hematol. 1993 Jul;30(3 Suppl 2):16-9. Semin Hematol. 1993. PMID: 8367738 No abstract available.
Is haemophilia prophylaxis achievable in the context of self-sufficiency?
Nilsson IM. Nilsson IM. Blood Coagul Fibrinolysis. 1994 Dec;5 Suppl 4:S71-5. doi: 10.1097/00001721-199412004-00019. Blood Coagul Fibrinolysis. 1994. PMID: 7795143
[Prophylaxis in patients with haemophilia complicated by inhibitors].
Paweł Ł. Paweł Ł. Pol Merkur Lekarski. 2011 Mar;30(177):211-4. Pol Merkur Lekarski. 2011. PMID: 21545000 Review. Polish.

See all similar articles

Cited by

Phase I study of BAY 94-9027, a PEGylated B-domain-deleted recombinant factor VIII with an extended half-life, in subjects with hemophilia A.
Coyle TE, Reding MT, Lin JC, Michaels LA, Shah A, Powell J. Coyle TE, et al. J Thromb Haemost. 2014 Apr;12(4):488-96. doi: 10.1111/jth.12506. J Thromb Haemost. 2014. PMID: 24843882 Free PMC article. Clinical Trial.
Extended Half-Life Coagulation Factors: A New Era in the Management of Hemophilia Patients.
Ar MC, Balkan C, Kavaklı K. Ar MC, et al. Turk J Haematol. 2019 Aug 2;36(3):141-154. doi: 10.4274/tjh.galenos.2019.2018.0393. Epub 2019 May 15. Turk J Haematol. 2019. PMID: 31088040 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information